deutivacaftor 50 MG / tezacaftor 20 MG / vanzacaftor 4 MG Oral Tablet
RxNorm concept 2701448, clinical drug (scd).
- RxCUI
- 2701448
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2701448 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
deutivacaftor 50 MG / tezacaftor 20 MG / vanzacaftor 4 MG (equivalent to vanzacaftor calcium dihydrate 4.24 MG) Oral Tablet
Related concepts
- vanzacaftor 4 MG (SCDC, consists of)
- tezacaftor 20 MG (SCDC, consists of)
- deutivacaftor 50 MG (SCDC, consists of)
- Oral Tablet (DF, has dose form)
- deutivacaftor 50 MG / tezacaftor 20 MG / vanzacaftor 4 MG Oral Tablet [Alyftrek] (SBD, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2701448 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2701448 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2701448. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.